Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Odyssey Health, Inc. incurred convertible notes of five hundred thousand ($500,000) with two accredited investors at 12% per annum maturing the later of twelve (12) months from execution or completion of a Senior Exchange Listing of the Company or a Company Spinout ("Spinco") of its ONP Technology.
- Instrument
- convertible notes
- Principal
- five hundred thousand ($500,000)
- Counterparty
- two accredited investors
- Rate
- 12% per annum
- Maturity
- the later of twelve (12) months from execution or completion of a Senior Exchange Listing of the Company or a Company Spinout ("Spinco") of its ONP Technology
- Event
- incurrence
Exact text from the filing
desires to issue and sell, as set forth in the NPA (i) a Convertible Promissory Note of the Company, (the “Note”), in aggregate principal amount of five hundred thousand ($500,000), (the “Loan Amount”), (ii) due and payable in full on or after the later of twelve (12) months from execution or completion of a Senior Exchange Listing of the Company or a
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
Odyssey Health, Inc. entered into Note Purchase Agreement with two accredited investors valued at aggregate principal amount of five hundred thousand ($500,000) (effective 2023-08-15).
- Action
- entry
- Agreement
- notes offering
- Counterparty
- two accredited investors
- Value
- aggregate principal amount of five hundred thousand ($500,000)
- Effective
- 2023-08-15
Exact text from the filing
On August 15, 2023, Odyssey Health, Inc., f/k/a Odyssey Group International, Inc. (the “Company”) entered into a Note Purchase Agreement (the “NPA”) with two accredited investors.
View on SEC.gov